EC5026
EC5026 (BPN-19186) is a first-in-class, non-opioid and orally active soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain[1].
Product Specifications
CAS Number
[1809885-32-2]
Product Name Alternative
BPN-19186
UNSPSC
12352005
Hazard Statement
H301
Target
Epoxide Hydrolase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ec5026.html
Purity
98.13
Solubility
DMSO : ≥ 250 mg/mL
Smiles
O=C(NC1CCN(C([C@@H](C)CC)=O)CC1)NC2=CC=C(OC(F)(F)F)C(F)=C2
Molecular Formula
C18H23F4N3O3
Molecular Weight
405.39
Precautions
H301
References & Citations
[1]EicOsis Announces FDA Acceptance of IND Application for EC5026, the First Soluble Epoxide Hydrolase Inhibitor to Treat Pain.2019.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Insulin-Like Growth Factor I Receptor, beta (IGF1Rb) (BSA & Azide Free) (APC) discontinued